Showing results (21-30 of 28) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
The Journal of Antimicrobial Chemotherapy|July 19, 2021
Estimated pill intake with on-demand PrEP with oral TDF/FTC using TFV-DP concentration in dried blood spots in the ANRS IPERGAY trialLauriane Goldwirt, Rebecca Bauer, Geoffroy Liegeon, et al.The Journal of Antimicrobial Chemotherapy|June 28, 2022
Once-daily dolutegravir versus darunavir plus cobicistat in adults at the time of primary HIV-1 infection: the OPTIPRIM2-ANRS 169 randomized, open-label, Phase 3 trialAntoine Chéret, Rebecca Bauer, Vincent Meiffrédy, et al.AIDS (London, England)|February 10, 2022
Incidence and risk factors for recurrent sexually transmitted infections among MSM on HIV pre-exposure prophylaxisJérémy Zeggagh, Rebecca Bauer, Constance Delaugerre, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|January 4, 2021
Evaluation of Drug Abuse by Hair Analysis and Self-Reported Use Among MSM Under PrEP: Results From a French Substudy of the ANRS-IPERGAY TrialJulie Chas, Rebecca Bauer, Islam Amine Larabi, et al.Infectious Diseases Now|March 17, 2024
Incidence of COVID-19 mRNA vaccine symptomatic breakthrough infections during Omicron circulation in adults with or without infection prior to vaccinationChristine Durier, Laetitia Ninove, Sylvie van der Werf, et al.Iscience|August 6, 2024
Cytokine profile of anti-spike CD4+T cells predicts humoral and CD8+T cell responses after anti-SARS-CoV-2 mRNA vaccinationNadine Benhamouda, Anissa Besbes, Rebecca Bauer, et al.Scientific Reports|November 27, 2022
Neutralizing antibodies against SARS-CoV-2 variants following mRNA booster vaccination in adults older than 65 yearsChristine Durier, Laetitia Ninove, Maeva Lefebvre, et al.JAMA Network Open|April 23, 2024
Serum and Salivary IgG and IgA Response After COVID-19 Messenger RNA VaccinationGuy Gorochov, Jacques Ropers, Odile Launay, et al.Pageof 3